Clarity Pharmaceuticals Ltd Stock
Stocks
CU6
AU0000165375
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
04:10:20 01/10/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2.100 AUD | 0.00% |
|
-0.47% | -37.87% |
| 27/08 | Clarity Pharmaceuticals Ltd Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 27/08 | Clarity Pharmaceuticals Fiscal 2026 Loss Widens, Revenue Up | MT |
| Market Cap | 783M 542M 482M 450M 411M 773M 52.22B 5.45B 2.11B 26.59B 2.04B 1.99B 85.42B | P/E 2027 * |
-6.63x | P/E 2028 * | -7.89x |
|---|---|---|---|---|---|
| Enterprise Value | 719M 498M 442M 414M 377M 710M 47.95B 5B 1.94B 24.42B 1.87B 1.83B 78.44B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 21.1x |
| Free-Float |
78.88% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CU6 | Delayed | |
Tradegate
| 1F4 | Real-time | |
|
Deutsche Boerse AG
| 1F4 | Delayed |
| 1 week | -0.47% | ||
| 1 month | -7.89% | ||
| 3 months | -1.87% | ||
| 6 months | -32.26% | ||
| Current year | -37.87% |
| 1 week | 2.01 |  | 2.15 |
| 1 month | 2.01 | | 2.42 |
| Current year | 1.8 | | 4.26 |
| 1 year | 1.8 | | 5.87 |
| 3 years | 0.98 | | 8.98 |
| 5 years | 0.36 | | 8.98 |
| 10 years | 0.36 | | 8.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michelle Parker
CEO | Chief Executive Officer | - | 11/10/2024 |
Matthew Harris
CEO | Chief Executive Officer | - | 01/01/2010 |
David Green
DFI | Director of Finance/CFO | - | 04/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Taylor
CHM | Chairman | - | 01/11/2013 |
Rosanne Robinson
BRD | Director/Board Member | - | 01/10/2010 |
Chris Roberts
BRD | Director/Board Member | 72 | 29/03/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/4/26 | Sell | Chief Executive Officer | 360,896 | 0.0969% | ||
| 28/11/25 | Free | Chief Operating Officer | 199,909 | 0.0537% | ||
| 28/11/25 | Free | Chief Operating Officer | 287,530 | 0.0773% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.47% | -41.01% | +79.49% | 545M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.69% | +36.36% | +82.72% | 60.14B | |
| -2.54% | -0.21% | +6.34% | +31.72% | 48.15B | |
| -3.02% | -2.67% | +37.26% | +32.51% | 44.25B | |
| +0.31% | +7.94% | +340.88% | +643.82% | 43.99B | |
| -1.96% | -1.71% | +5.30% | +99.46% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -4.86% | -8.24% | -24.60% | +330.06% | 24.93B | |
| Average | -0.04% | +1.72% | +45.79% | +146.80% | 39.73B | |
| Weighted average by Cap. | +0.18% | +1.83% | +59.93% | +145.69% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 33.03M 22.87M 20.31M 18.99M 17.31M 32.59M 2.2B 230M 88.95M 1.12B 85.85M 83.99M 3.6B |
| Net income | -121M -83.55M -74.21M -69.4M -63.24M -119M -8.04B -840M -325M -4.1B -314M -307M -13.16B | -101M -69.97M -62.15M -58.12M -52.96M -99.7M -6.74B -703M -272M -3.43B -263M -257M -11.02B |
| Net Debt | -64M -44.3M -39.35M -36.8M -33.53M -63.13M -4.27B -445M -172M -2.17B -166M -163M -6.98B | -87M -60.22M -53.49M -50.02M -45.58M -85.82M -5.8B -605M -234M -2.95B -226M -221M -9.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | $2.100 | 0.00% | 1,834,367 |
| 30/09/26 | $2.100 | -0.47% | 1,344,732 |
| 29/09/26 | $2.110 | +3.94% | 1,552,537 |
| 28/09/26 | $2.030 | -3.79% | 2,024,039 |
| 25/09/26 | $2.110 | +0.96% | 1,302,047 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CU6 Stock
Select your edition
All financial news and data tailored to specific country editions
